Among these are VLA-4 and CD38,[1]–[3] two surface molecules that are believed not only to be mere markers of disease aggressiveness but also to play a role in CLL pathogenesis. The gene discussed is CD38; the disease is B-cell chronic lymphocytic leukemia.